Direct characterization of amyloidogenic oligomers by single-molecule fluorescence.
A key issue in understanding the pathogenic conditions associated with the aberrant aggregation of misfolded proteins is the identification and characterization of species formed during the aggregation process. Probing the nature of such species has, however, proved to be extremely challenging to conventional techniques because of their transient and heterogeneous character. We describe here the application of a two-color single-molecule fluorescence technique to examine the assembly of oligomeric species formed during the aggregation of the SH3 domain of PI3 kinase. The single-molecule experiments show that the species formed at the stage of the reaction where aggregates have previously been found to be maximally cytotoxic are a heterogeneous ensemble of oligomers with a median size of 38 +/- 10 molecules. This number is remarkably similar to estimates from bulk measurements of the critical size of species observed to seed ordered fibril formation and of the most infective form of prion particles. Moreover, although the size distribution of the SH3 oligomers remains virtually constant as the time of aggregation increases, their stability increases substantially. These findings together provide direct evidence for a general mechanism of amyloid aggregation in which the stable cross-beta structure emerges via internal reorganization of disordered oligomers formed during the lag phase of the self-assembly reaction.
Orte
Angel
A
Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, United Kingdom.
Birkett
Neil R
NR
Clarke
Richard W
RW
Devlin
Glyn L
GL
Dobson
Christopher M
CM
Klenerman
David
D
D000682:Amyloid / Q000737:chemistry* / Q000378:metabolism*; D000818:Animals; D002417:Cattle; D005453:Fluorescence; D007700:Kinetics; D019869:Phosphatidylinositol 3-Kinases / Q000737:chemistry / Q000378:metabolism; D017510:Protein Folding; D013050:Spectrometry, Fluorescence; D018909:src Homology Domains
D000682:Amyloid; D019869:Phosphatidylinositol 3-Kinases
J Mol Biol. 2003 Nov 14;334(1):129-41
14596805
Annu Rev Biochem. 1997;66:385-407
9242912
J Mol Biol. 2006 Feb 10;356(1):189-208
16364365
J Biol Chem. 2006 Jun 2;281(22):15337-44
16571726
PLoS Comput Biol. 2007 Sep;3(9):1727-38
17941703
J Biol Chem. 2004 Jul 23;279(30):31374-82
15133040
Nature. 2005 Sep 8;437(7056):257-61
16148934
Nature. 2002 Apr 4;416(6880):535-9
11932745
Anal Chem. 2006 Nov 15;78(22):7707-15
17105162
J Biol Chem. 2006 Jun 23;281(25):16888-16896
16624810
EMBO J. 1999 Feb 15;18(4):815-21
10022824
Am J Pathol. 1999 Sep;155(3):853-62
10487842
J Am Chem Soc. 2003 Dec 17;125(50):15359-65
14664580
Brain Res. 1994 Feb 21;637(1-2):339-41
8180816
Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19232-7
18042730
J Neurosci. 2006 Aug 2;26(31):8160-7
16885229
Cell. 1993 May 21;73(4):813-22
7684655
Anal Chem. 2003 Apr 1;75(7):1664-70
12705600
Nature. 2003 Dec 18;426(6968):884-90
14685248
FEBS Lett. 2006 May 1;580(10):2451-7
16638570
Science. 2003 Apr 18;300(5618):486-9
12702875
Front Biosci. 2008 May 01;13:5614-22
18508610
J Mol Biol. 1995 Feb 3;245(5):461-6
7844819
Nature. 2002 Apr 4;416(6880):507-11
11932737
J Biol Chem. 2005 Apr 29;280(17):17294-300
15722360
Annu Rev Biochem. 2006;75:333-66
16756495
Ann Neurol. 1999 Dec;46(6):860-6
10589538
Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4224-8
9539718
Anal Chem. 2007 Apr 1;79(7):2771-7
17343363
Nature. 2005 Jul 28;436(7050):554-8
16049488
Science. 2000 Aug 25;289(5483):1317-21
10958771
J Mol Biol. 2001 Aug 10;311(2):325-40
11478864